HomeCompaniesEvolvere BioSciences

Evolvere BioSciences

Making Next-Generation Antibiotics that Outpace Bacterial Evolution

🦠🤖 We use our computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells. ☠️ Current antibiotics stop working because bacteria evolve resistance to them. This makes drug-resistant bacteria a looming global health crisis - already killing more people than malaria and AIDS and it is getting exponentially worse 📈. 🧬 Our approach leverages co-evolutionary protein-protein interaction datasets combined with AI to forecast bacterial mutations and create ‘future-proof’ antibiotics, addressing antibiotic resistance before it develops. This changes the game for how frequently society will need to make new antibiotics and how long our new antibiotics will be able to treat patients 👩‍⚕️. We are a team of biochemists and evolutionary biologists who met at the University of Oxford.
Evolvere BioSciences
Founded:2021
Team Size:3
Status:
Active
Location:Oxford, United Kingdom
Active Founders

Adam Winnifrith, Founder

Evolvere (S24), CEO & Co-Founder, MBioChem Oxford, I work at the intersection of bioengineering, protein AI, and automation. E.S.B
Adam Winnifrith
Adam Winnifrith
Evolvere BioSciences

Piotr Jedryszek, Founder

S24, Evolvere Biosciences, CTO and Co-founder, background in Bio and CompBio
Piotr Jedryszek
Piotr Jedryszek
Evolvere BioSciences

Weronika Slesak, Founder

CSO at Evolvere (S24). Oxford biologist using evolution as an engineering tool.
Weronika Slesak
Weronika Slesak
Evolvere BioSciences